5 results match your criteria: "University Hospital of Copenhagen Gentofte[Affiliation]"
A first case of occupational allergic contact dermatitis due to Tinuvin 770.
Contact Dermatitis
December 2024
Department of Dermatology and Allergy, Copenhagen University Hospital, Hellerup, Denmark.
Filaggrin Mutation Status and Prevention of Atopic Dermatitis with Maternal Probiotic Supplementation.
Acta Derm Venereol
April 2024
Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
The World Allergy Organization recommends probiotics in the prevention of atopic dermatitis in high-risk populations. Mutations in the filaggrin gene (FLG) result in an increased risk of atopic dermatitis through disruption of the skin keratin layer. This exploratory study investigated whether the preventive effect of maternal probiotics was evident in children with and without FLG mutations.
View Article and Find Full Text PDFEfficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque psoriasis.
J Am Acad Dermatol
August 2018
Eli Lilly and Company, Indianapolis, Indiana.
Background: Ixekizumab has demonstrated improvement in patients with moderate-to-severe psoriasis by selectively targeting interleukin-17A, which is a proinflammatory cytokine that is important in the pathogenesis of psoriasis.
Objective: To report 4-year efficacy and safety results from the open-label extension (OLE) of this phase 2 trial.
Methods: Analysis was by last observation carried forward.
Impaired hapten sensitization in patients with autoimmune disease.
Clin Exp Immunol
September 2011
Department of Dermato-allergology, University Hospital of Copenhagen Gentofte, Hellerup, Denmark.
An inverse relation between contact allergy and autoimmune diseases is suggested from epidemiological studies. The aim of this study was to investigate susceptibility and reactivity in patients with psoriasis, patients with diabetes and healthy controls in an experimental sensitization study. We sensitized 68 adult individuals (23 patients with psoriasis, 22 patients with diabetes and 23 healthy controls) with diphenylcyclopropenone (DPCP) and assessed challenge responses with visual scoring and ultrasound.
View Article and Find Full Text PDFNephrogenic systemic fibrosis: late skin manifestations.
Arch Dermatol
February 2009
Department of Dermatology, University Hospital of Copenhagen Gentofte, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.
Background: Nephrogenic systemic fibrosis (NSF) is a serious disease that occurs in patients with severe renal disease and is believed to be caused by gadolinium-containing contrast agents. A detailed description of the late skin manifestations of NSF is important to help dermatologists and nephrologists recognize the disease.
Observations: We studied 17 patients with NSF late in the disease.